熱門資訊> 正文
InflaRx GAAP每股收益为-0.13欧元
2025-05-07 19:37
- InflaRx press release (NASDAQ:IFRX): Q1 GAAP EPS of -€0.13.
- As of March 31, 2025, our total funds available amounted to approximately €65.7 million, comprised of €47.3 million of cash and cash equivalents and €18.4 million of marketable securities.
- Net cash used in operating activities decreased to €14.0 million in the three months ended March 31, 2025, from €14.9 million in the three months ended March 31, 2024.
More on InflaRx
- InflaRx dips 16%, prices $30M stock offering
- InflaRx commences offering of ordinary shares and pre-funded warrants
- Seeking Alpha’s Quant Rating on InflaRx
- Historical earnings data for InflaRx
- Financial information for InflaRx
推薦文章
風險及免責提示：以上內容僅代表作者的個人立場和觀點，不代表華盛的任何立場，華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前，應結合自身情況，考慮投資產品的風險。必要時，請諮詢專業投資顧問的意見。華盛不提供任何投資建議，對此亦不做任何承諾和保證。
